INDIANAPOLIS, Nov. 29,
2022 /PRNewswire/ -- Eli Lilly and Company (NYSE:
LLY) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022. Lilly will also conduct a
conference call on that day with the investment community and media
to further detail the company's financial guidance.
The conference call will begin at 9 a.m.
Eastern time. Investors, media and the general public can
access a live webcast of the conference call through a link that
will be posted on Lilly's website at
https://investor.lilly.com/webcasts-and-presentations. A replay
will also be available on the website following the conference
call.
About Lilly
Lilly unites caring with discovery to
create medicines that make life better for people around the world.
We've been pioneering life-changing discoveries for nearly 150
years, and today our medicines help more than 47 million
people across the globe. Harnessing the power of biotechnology,
chemistry and genetic medicine, our scientists are urgently
advancing new discoveries to solve some of the world's most
significant health challenges, redefining diabetes care, treating
obesity and curtailing its most devastating long-term effects,
advancing the fight against Alzheimer's disease, providing
solutions to some of the most debilitating immune system disorders,
and transforming the most difficult-to-treat cancers into
manageable diseases. With each step toward a healthier world, we're
motivated by one thing: making life better for millions more
people. That includes delivering innovative clinical trials that
reflect the diversity of our world and working to ensure our
medicines are accessible and affordable. To learn more,
visit Lilly.com and Lilly.com/newsroom or
follow us on Facebook, Instagram and LinkedIn. F-LLY
Refer
to:
|
Jordan Bishop;
jordan.bishop@lilly.com; 317-473-5712 (Media)
|
|
Joe Fletcher;
jfletcher@lilly.com; 317-296-2884 (Investors)
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/lilly-confirms-date-and-conference-call-for-2023-financial-guidance-announcement-301688165.html
SOURCE Eli Lilly and Company